Creative Planning Makes New $725,000 Investment in GRAIL, Inc. $GRAL

Creative Planning purchased a new stake in GRAIL, Inc. (NASDAQ:GRAL) during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 14,093 shares of the company’s stock, valued at approximately $725,000.

Other institutional investors and hedge funds also recently modified their holdings of the company. Wealth Enhancement Advisory Services LLC lifted its stake in GRAIL by 21.4% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 34,195 shares of the company’s stock valued at $1,758,000 after acquiring an additional 6,032 shares in the last quarter. Scientech Research LLC acquired a new stake in shares of GRAIL in the first quarter valued at approximately $644,000. Bay Colony Advisory Group Inc d b a Bay Colony Advisors bought a new stake in shares of GRAIL in the second quarter worth $233,000. Wesbanco Bank Inc. boosted its holdings in GRAIL by 39.1% during the second quarter. Wesbanco Bank Inc. now owns 44,500 shares of the company’s stock worth $2,288,000 after purchasing an additional 12,500 shares during the last quarter. Finally, Dakota Wealth Management acquired a new position in GRAIL during the second quarter worth $2,656,000.

Insiders Place Their Bets

In related news, CEO Robert P. Ragusa sold 7,239 shares of the company’s stock in a transaction dated Wednesday, October 15th. The shares were sold at an average price of $68.88, for a total value of $498,622.32. Following the transaction, the chief executive officer owned 727,388 shares in the company, valued at approximately $50,102,485.44. This represents a 0.99% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, President Joshua J. Ofman sold 6,114 shares of the stock in a transaction dated Thursday, October 16th. The shares were sold at an average price of $82.01, for a total transaction of $501,409.14. Following the completion of the transaction, the president directly owned 381,818 shares in the company, valued at approximately $31,312,894.18. This represents a 1.58% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 113,295 shares of company stock worth $7,380,888.

GRAIL Stock Performance

GRAIL stock opened at $97.38 on Wednesday. The stock has a 50-day simple moving average of $80.92 and a 200 day simple moving average of $53.64. The stock has a market capitalization of $3.80 billion, a P/E ratio of -8.37 and a beta of 4.23. GRAIL, Inc. has a 52 week low of $16.10 and a 52 week high of $115.76.

GRAIL (NASDAQ:GRAL) last released its quarterly earnings data on Wednesday, November 12th. The company reported ($2.46) earnings per share (EPS) for the quarter, beating the consensus estimate of ($3.40) by $0.94. GRAIL had a negative return on equity of 15.69% and a negative net margin of 286.43%.The firm had revenue of $36.19 million for the quarter, compared to analyst estimates of $33.83 million. Research analysts forecast that GRAIL, Inc. will post -15.15 earnings per share for the current year.

Analysts Set New Price Targets

Several equities research analysts have issued reports on the stock. Guggenheim upgraded shares of GRAIL from a “neutral” rating to a “buy” rating and set a $100.00 price target on the stock in a research note on Wednesday, November 12th. Canaccord Genuity Group upped their target price on GRAIL from $85.00 to $105.00 and gave the stock a “buy” rating in a report on Monday, November 17th. Morgan Stanley increased their price target on GRAIL from $85.00 to $110.00 and gave the company an “equal weight” rating in a research report on Monday. UBS Group set a $75.00 price target on GRAIL in a research note on Friday, October 3rd. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of GRAIL in a research note on Wednesday, October 8th. Two investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $97.50.

GRAIL Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.